We are live on ! Find out more
LPCN icon

Lipocine
LPCN

17 hedge funds and large institutions have $23.7M invested in Lipocine in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

7% more capital invested

Capital invested by funds: $22.2M → $23.7M (+$1.49M)

6% more funds holding

Funds holding: 16 → 17 (+1)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
+$8.82M
2
VM
VHCP Management
New York
+$3.86M
3
GTC
Ghost Tree Capital
New York
+$671K
4
Millennium Management
Millennium Management
New York
+$645K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$389K

Top Sellers

Rank Fund Capital Flow
1
JHIU
Janus Henderson Investors US
Colorado
-$3.92M
2
TCP
Tourbillon Capital Partners
New York
-$2.75M
3
SM
Sabby Management
Florida
-$2.54M
4
BC
Broadfin Capital
New York
-$1.61M
5
WC
Wexford Capital
Florida
-$1.14M

LPCN Hedge Fund Activity: Q3 2014 in Review

17 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2014, worth a combined $23.7M — up 6.7% from $22.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LPCN positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $8.82M. The largest seller was Janus Henderson Investors US, cutting an estimated $3.92M.

  • 17 institutional investors held Lipocine (LPCN) as of Q3 2014, up from 16 in Q2 2014.
  • Funds reported $23.7M of Lipocine stock for Q3 2014, up 6.7% quarter-over-quarter.
  • 6 funds opened new Lipocine positions in Q3 2014 and 5 closed out, a net change of +1 holder.
  • The largest Lipocine buyer in Q3 2014 was Visium Asset Management, an estimated $8.82M added.
  • The largest Lipocine seller in Q3 2014 was Janus Henderson Investors US, an estimated $3.92M sold.

Based on aggregated 13F filings for Q3 2014.